Citadel Advisors »

Sensei Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Sensei Biotherapeutics (FTH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $307k 12k 25.00

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Sensei Biotherapeutics

Suvretta Capital Management
venBio Select Advisor
Baker Bros. Advisors
Balyasny Asset Management
Cormorant Asset Management
RA Capital Management
Vivo Capital
Fairmount Funds Management
Logos Global Management
Caligan Partners
Trails Edge Capital Partners
Franklin Resources
Octagon Capital Advisors
ADAR1 Capital Management
Marshall Wace

View all funds holding Sensei Biotherapeutics